Abstract
Although subclinical liver disease is common in systemic lupus erythematosus (SLE), strikingly high levels of liver enzymes are rare. Our aim was to determine the cause of high levels of liver enzymes in lupus patients, particularly in patients diagnosed with toxic hepatitis. We performed a retrospective chart review of SLE patients treated at the Inje University Hospital between 2001 and 2008. We defined liver enzyme abnormality as a twofold or greater increase in two or more of the following four components: total bilirubin, AST, ALT and LDH or ALP. Acute toxic hepatitis was diagnosed by a score ≥5 in the Roussel Uclaf Causality Assessment Method. Of 141 SLE patients 46 (32.6%) met strict criteria for the liver enzyme abnormality. In total, 11 patients (7.8%) in this study had presumed toxic hepatitis associated with either herbal medicines (n = 6), anti-tuberculosis medications (n = 3), antibiotics (n = 1) or valproic acid (n = 1). There were striking laboratory abnormalities in the groups diagnosed with toxic hepatitis (mean peak values: AST 775 ± 464 U/L, ALT 400 ± 447 U/L, ALP 767 ± 408 U/L, LDH 1,469 ± 779 U/L). All six patients with herbal-induced toxic hepatitis were in the active SLE state. After cessation of the suspected causative medication and subsequent administration of steroids, liver enzyme levels were improved. Herbal medicines and anti-tuberculosis medications, known to cause toxic hepatitis, can also induce increased liver enzyme levels in lupus patients. However, since most herbal medicines contain a mixture of various products, we could not ascertain what specific ingredient induced the increase in liver enzyme levels.
Similar content being viewed by others
References
Hallegua DS, Wallace DJ (2002) Gastrointestinal manifestation and hepatic manifestation. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott William & Wilkins, Philadelphia, pp 843–861
Pittler MH, Ernst E (2003) Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 18:451–471
Stickel F, Patsenker E, Schuppan D (2005) Herbal hepatotoxicity. J Hepatol 43:901–910
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640
Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs—i. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330
Benichou C, Danan G, Flahault A (1993) Causality assessment of adverse reactions to drugs—ii. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 46:1331–1336
Czaja AJ, Freese DK (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36:479–497
Gibson T, Myers AR (1981) Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 8:752–759
Runyon BA, La Brecque DR, Anuras S (1980) The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med 69:187–194
Kang SH, Kim JI, Jeong KH, Ko KH, Ko PG, Hwang S et al (2008) Clinical characteristics of 159 cases of acute toxic hepatitis. Korean J Hepatol 14:483–492
Miller MH, Urowitz MB, Gladman DD, Blendis LM (1984) The liver in systemic lupus erythematosus. Q J Med 53:401–409
Lai NS, Lin RH, Lai RS, Kun UC, Leu SC (2001) Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice with an ancient Chinese herb, Ganoderma tsugae. Lupus 10:461–465
Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med 349:474–485
Seeff LB (2007) Herbal hepatotoxicity. Clin Liver Dis 11:577–596, vii
Andrade RJ, Robles M, Fernandez-Castaner A, Lopez-Ortega S, Lopez-Vega M et al (2007) Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol 13:329–340
Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C (1997) Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 92:703–704
Rubin RL (2005) Drug-induced lupus. Toxicology 209:135–147
Chitturi S, Farrell GC (2000) Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 15:1093–1099
Acknowledgments
This work was supported by a 2008 Inje university research grant (Her M).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Her, M., Lee, Y., Jung, E. et al. Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis. Rheumatol Int 31, 79–84 (2011). https://doi.org/10.1007/s00296-009-1237-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1237-4